Skip to content

The effect of flaxseed powder on the treatment of polycystic ovarian syndrome

Effect of flaxseed powder on levels of the glycemic indices, lipid Profile, inflammatory factors, adipocytokines and androgen profile in women with polycystic ovarian syndrome

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20120704010181N11
Enrollment
56
Registered
2018-01-21
Start date
2017-11-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic ovarian syndrome. Polycystic ovarian syndrome

Interventions

Intervention group: Patients with polycystic ovarian syndrome who receive a daily dose of 30 grams of flaxseed for 12 weeks together with recommendations for lifestyle modification..
Treatment - Other
Intervention group: Patients with polycystic ovarian syndrome who receive a daily dose of 30 grams of flaxseed for 12 weeks together with recommendations for lifestyle modification.

Sponsors

Ahvaz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: Patients with polycystic ovarian syndrome BMI less than 35 kg/m2

Exclusion criteria

Exclusion criteria: Chronic diseases such as heart disease, diabetes, cancer, Thyroid gland disorders Following the weight loss program in the last 6 months. Taking any nutritional supplement Pregnancy

Design outcomes

Primary

MeasureTime frame
Testosterone levels. Timepoint: At the beginning and end of the study. Method of measurement: Using ELISA Kit.;SHBG levels. Timepoint: At the beginning and end of the study. Method of measurement: Using ELISA Kit.;Serum levels of insulin. Timepoint: At the beginning and end of the study. Method of measurement: Using ELISA Kit.;Insulin resistance. Timepoint: At the beginning and end of the study. Method of measurement: Using HOMA-IR equation.;Insulin sensitivity. Timepoint: At the beginning and end of the study. Method of measurement: Using QUICKI equation.

Secondary

MeasureTime frame
Grade Hirsutism Based on Freeman Galway questionnaire, Score more than 8. Timepoint: At the beginning and end of the study. Method of measurement: Based on Freeman Gallo's Questionnaire.;Menstrual Cycle. Timepoint: At the beginning and end of the study. Method of measurement: Based on individual interviews.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNasrin Banaei

Ahvaz University of Medical Sciences

banaei.n@ajums.ac.ir+98 61 3373 8383

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 19, 2026